What is hemostatus
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive information from Robbins & Kumar Basic Pathology. Here is a complete answer:
Hemostasis
Hemostasis is the precisely orchestrated physiological process that stops bleeding at a site of vascular injury by forming a blood clot. It involves three main components: platelets, clotting factors (coagulation cascade), and the endothelium.
Sequence of Events
1. Arteriolar Vasoconstriction
Immediately after injury, the vessel constricts to reduce blood flow. This is triggered by neurogenic reflexes and local release of endothelin (a potent vasoconstrictor from endothelium). This effect is transient and insufficient on its own.
2. Primary Hemostasis — Platelet Plug Formation
- Endothelial disruption exposes subendothelial collagen, which binds von Willebrand factor (vWF).
- vWF promotes platelet adhesion via the platelet receptor GpIb.
- Activated platelets undergo a shape change (rounded discs → flat plates with spiky protrusions) and release secretory granules.
- Released ADP and thromboxane A₂ (TXA₂) recruit additional platelets, which aggregate via fibrinogen bridging the GpIIb-IIIa receptor → forming the primary hemostatic plug.
3. Secondary Hemostasis — Coagulation Cascade & Fibrin Deposition
- Vascular injury exposes tissue factor (TF), a membrane-bound procoagulant glycoprotein normally on subendothelial smooth muscle cells and fibroblasts.
- TF binds and activates factor VII, triggering the extrinsic coagulation cascade.
- The cascade culminates in thrombin generation.
- Thrombin cleaves circulating fibrinogen → insoluble fibrin, creating a meshwork that consolidates the platelet plug → secondary hemostatic plug.
- Thrombin also potently activates more platelets, amplifying aggregation.
4. Clot Stabilization
- Factor XIII covalently cross-links fibrin polymers.
- Platelet contraction compacts the clot into a solid, permanent plug.
- Counterregulatory mechanisms limit the clot to the injury site and eventually lead to fibrinolysis and tissue repair.
The Coagulation Cascade
The cascade has two arms:
- Extrinsic pathway: Tissue factor + Factor VII → Factor Xa
- Intrinsic pathway: Factors XII → XI → IX → VIII → Factor Xa
- Both converge on the common pathway: Factor Xa + Va → Thrombin → Fibrin
Key concepts:
- Coagulation factors circulate as inactive zymogens and are sequentially activated.
- Several factors (II, VII, IX, X, protein C, protein S) require vitamin K for synthesis — this is the basis of warfarin's anticoagulant effect.
- Thrombin is the central effector: it generates fibrin, activates platelets, activates factors V, VIII, XI, and XIII, and activates protein C (anticoagulant feedback).
Fibrinolysis — Limiting the Clot
To prevent excessive clotting, the fibrinolytic system dissolves clots:
- Endothelial cells release tissue plasminogen activator (t-PA) and urokinase.
- These convert plasminogen (bound to the fibrin clot) → plasmin.
- Plasmin degrades fibrin into fibrin degradation products (FDPs/D-dimers).
- Free plasmin is rapidly neutralized by α₂-plasmin inhibitor.
- Plasminogen activator inhibitors (PAI-1, PAI-2) from endothelium limit excessive fibrinolysis.
Role of the Endothelium (Antithrombotic Balance)
Normal, healthy endothelium is antithrombotic:
| Mechanism | Effect |
|---|---|
| PGI₂ (prostacyclin) and NO | Inhibit platelet activation; promote vasodilation |
| Adenosine diphosphatase | Degrades ADP, preventing platelet aggregation |
| Thrombomodulin | Binds thrombin; shifts it toward activating protein C (anticoagulant) |
| Protein C / Protein S | Inhibit coagulation factors Va and VIIIa |
| Heparin-like molecules | Activate antithrombin III → inhibits thrombin, IXa, Xa, XIa, XIIa |
| TFPI | Inhibits tissue factor / factor VIIa complexes |
| t-PA | Promotes fibrinolysis |
When endothelium is injured or inflamed, this balance shifts to a procoagulant state, predisposing to thrombosis.
Clinical Relevance
| Disorder | Mechanism |
|---|---|
| Hemophilia A/B | Deficiency of factor VIII or IX → impaired intrinsic pathway |
| von Willebrand disease | Reduced/defective vWF → impaired platelet adhesion |
| Thrombocytopenia | Low platelets → impaired primary hemostasis |
| DIC | Systemic activation of coagulation → consumption of clotting factors and platelets |
| DVT/PE | Virchow's triad (stasis, endothelial injury, hypercoagulability) → pathological thrombosis |
— Robbins & Kumar Basic Pathology
This is a shared conversation. Sign in to Orris to start your own chat.